4928 related articles for article (PubMed ID: 4549213)
1. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
de Vries JE; Cornain S; Rumke P
Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
[No Abstract] [Full Text] [Related]
2. Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells.
Wybran J; Hellström I; Hellström KE; Fudenberg HH
Int J Cancer; 1974 Apr; 13(4):515-21. PubMed ID: 4546321
[No Abstract] [Full Text] [Related]
3. Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells.
Saal JG; Rieber EP; Hadam M; Riethmuller G
Nature; 1977 Jan; 265(5590):158-60. PubMed ID: 299919
[No Abstract] [Full Text] [Related]
4. [Immunologic reaction-readiness in malignant melanoma].
Bickhardt R; Kunze J
Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
[No Abstract] [Full Text] [Related]
5. Antibody dependent cellular cytotoxicity: cytotoxicity mediated by non t-lymphocytes.
Zighelboim J; Gale RP; Chiu A; Bonavida B; Ossorio RC; Fahey JL
Clin Immunol Immunopathol; 1974 Nov; 3(2):193-200. PubMed ID: 4548867
[No Abstract] [Full Text] [Related]
6. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.
Yust I; Wunderlich JR; Mann DL; Buell DN
J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926
[No Abstract] [Full Text] [Related]
7. The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication.
Thornes RD; Smyth H; Browne O; O'Gorman M; Reen DJ; Farrell D; Holland PD
J Med; 1974; 5(1):92-7. PubMed ID: 4275505
[No Abstract] [Full Text] [Related]
8. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors.
de Vries JE; Meyering M; van Dongen A; Rümke P
Int J Cancer; 1975 Mar; 15(3):391-400. PubMed ID: 1056313
[TBL] [Abstract][Full Text] [Related]
9. Immunology of human malignant melanoma.
Lewis MG
Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
[No Abstract] [Full Text] [Related]
10. Characterization of subpopulations of human lymphoid cells participating in phytohemagglutinin and concanavalin A-induced cytotoxicity.
Wisloff F; Froland SS; Michaelsen TE
Int Arch Allergy Appl Immunol; 1974; 47(4):488-97. PubMed ID: 4547156
[No Abstract] [Full Text] [Related]
11. Characterization of suppressor cells in mice with a transplantable malignant melanoma.
Stelzer GT; Wallace JH
Oncology; 1980; 37(6):397-405. PubMed ID: 6448970
[TBL] [Abstract][Full Text] [Related]
12. T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia.
Brouet JC; Toben HR; Chevalier A; Seligmann M
Ann Immunol (Paris); 1974; 125 C(5):691-6. PubMed ID: 4617552
[No Abstract] [Full Text] [Related]
13. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
14. [Surface receptors in human lymphocytes].
Nowak J
Pol Arch Med Wewn; 1975 Jul; 54(1):55-66. PubMed ID: 50596
[No Abstract] [Full Text] [Related]
15. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
O'Neill PA; Mackler BF; Romsdahl MM
J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
[TBL] [Abstract][Full Text] [Related]
16. A comparison of human lymphoid cells in antibody-dependent cellular cytotoxicity (ADCC).
Gale RP; Zighelboim J; Ossorio RC; Fahey JL
Clin Immunol Immunopathol; 1975 Jan; 3(3):377-84. PubMed ID: 1167324
[No Abstract] [Full Text] [Related]
17. In vitro correlates of cell-mediated immunity in the human.
Bach JF
Boll Ist Sieroter Milan; 1974; 53(1):suppl:161-73. PubMed ID: 4277530
[No Abstract] [Full Text] [Related]
18. Lymphocyte anergy in patients with carcinoma.
Nind AP; Nairn RC; Rolland JM; Guli EP; Hughes ES
Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for melanoma.
Vaisrub S
JAMA; 1973 Sep; 225(10):1242. PubMed ID: 4542440
[No Abstract] [Full Text] [Related]
20. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
